Building America’s Future, a nonprofit advocacy group that previously focused on trade, infrastructure, and tobacco issues, recently pushed into drug [...] …
Blog Posts
Key committees in the Mississippi state house and senate last week approved companion bills that would prohibit drugmaker 340B contract [...] …
The Minnesota Department of Health (MDH) last Friday released its final guidance on one of the first state 340B provider [...] …
Drugmaker Liquidia will implement contract pharmacy restrictions for a single drug that has a still-pending new drug application (NDA). The [...] …
The Virginia house today overwhelmingly cleared a bill to bar drugmaker 340B contract pharmacy restrictions, two weeks after the state [...] …
Two bills introduced in Oregon and Utah to bar drugmaker 340B contract pharmacy restrictions are now effectively dead, and provider [...] …
After missing its self-imposed deadline of publishing the 340B administrative dispute resolution final rule by the end of 2023, the [...] …
SPONSORED CONTENT
Join us for in an informative and timely 340B webinar scheduled for March 13th at 11:30 AM CT! Ted Slafsky, CEO of 340B Report, and Kristin Fox-Smith from Visante will share insights on 340B policy and litigation updates, along with valuable strategies to enhance and streamline your 340B program. Registration is complimentary, but spots are limited, so secure your spot today!
Idaho state lawmakers this week introduced a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy benefit [...] …
After implementing its first contract pharmacy restrictions in January, Japanese pharmaceutical giant Takeda recently subjected another drug to conditions on [...] …